P
US8987232B2ActiveUtilityPatentIndex 73

Agent for ameliorating brain hypofunction

Assignee: SHIOTA KUNIOPriority: Sep 4, 2008Filed: Feb 25, 2011Granted: Mar 24, 2015
Est. expirySep 4, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Inventors:SHIOTA KUNIOKUWAHARA MASAYOSHIKIKUSUI TAKEFUMIYAGI SHINTARO
A61P 25/28A61K 31/7008A61P 25/00
73
PatentIndex Score
5
Cited by
16
References
4
Claims

Abstract

Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier, and a food comprising N-acetyl-D-mannosamine added thereto.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method of ameliorating or treating a sleep interruption due to premature arousal in a subject in need thereof, comprising administering an effective amount of N-acetyl-D-mannosamine to the subject. 
     
     
       2. A method of ameliorating a sleep interruption due to premature arousal in a subject in need thereof, comprising allowing an effective amount of N-acetyl-D-mannosamine to be taken by the subject. 
     
     
       3. The method of  claim 2 , wherein the subject is a human. 
     
     
       4. The method of  claim 1 , wherein the subject is a human.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.